These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22800372)

  • 21. Detecting ligands and dissecting nuclear receptor-signaling pathways using recombinant strains of the yeast Saccharomyces cerevisiae.
    Fox JE; Burow ME; McLachlan JA; Miller CA
    Nat Protoc; 2008; 3(4):637-45. PubMed ID: 18388946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging of selective nuclear receptor modulator-induced conformational changes in the nuclear receptor to allow interaction with coactivator and corepressor proteins in living cells.
    Awais M; Sato M; Umezawa Y
    Chembiochem; 2007 May; 8(7):737-43. PubMed ID: 17387660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Panning for SNuRMs: using cofactor profiling for the rational discovery of selective nuclear receptor modulators.
    Kremoser C; Albers M; Burris TP; Deuschle U; Koegl M
    Drug Discov Today; 2007 Oct; 12(19-20):860-9. PubMed ID: 17933688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors.
    Voegel JJ; Heine MJ; Zechel C; Chambon P; Gronemeyer H
    EMBO J; 1996 Jul; 15(14):3667-75. PubMed ID: 8670870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity relationship of nuclear receptor-ligand interactions.
    Greschik H; Moras D
    Curr Top Med Chem; 2003; 3(14):1573-99. PubMed ID: 14683516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors.
    Hu X; Lazar MA
    Nature; 1999 Nov; 402(6757):93-6. PubMed ID: 10573424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of novel nuclear receptor modulating ligands: an integral role for peptide interaction profiling.
    Pearce KH; Iannone MA; Simmons CA; Gray JG
    Drug Discov Today; 2004 Sep; 9(17):741-51. PubMed ID: 15450240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beyond the ligand-binding pocket: targeting alternate sites in nuclear receptors.
    Caboni L; Lloyd DG
    Med Res Rev; 2013 Sep; 33(5):1081-118. PubMed ID: 23344935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulated histone methyltransferase and demethylase complexes in the control of genes by nuclear receptors.
    Yokoyama A; Fujiki R; Ohtake F; Kato S
    Cold Spring Harb Symp Quant Biol; 2011; 76():165-73. PubMed ID: 21890642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-talk between nuclear receptors and nuclear factor kappaB.
    De Bosscher K; Vanden Berghe W; Haegeman G
    Oncogene; 2006 Oct; 25(51):6868-86. PubMed ID: 17072333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The coactivator LXXLL nuclear receptor recognition motif.
    Savkur RS; Burris TP
    J Pept Res; 2004 Mar; 63(3):207-12. PubMed ID: 15049832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small targeted cytotoxics: current state and promises from DNA-encoded chemical libraries.
    Krall N; Scheuermann J; Neri D
    Angew Chem Int Ed Engl; 2013 Jan; 52(5):1384-402. PubMed ID: 23296451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NRLiSt BDB, the manually curated nuclear receptors ligands and structures benchmarking database.
    Lagarde N; Ben Nasr N; Jérémie A; Guillemain H; Laville V; Labib T; Zagury JF; Montes M
    J Med Chem; 2014 Apr; 57(7):3117-25. PubMed ID: 24666037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Editorial for Special Issue on "Alternative nuclear receptor ligands".
    Moore TW; Frasor J
    Mol Cell Endocrinol; 2019 Aug; 493():110479. PubMed ID: 31173820
    [No Abstract]   [Full Text] [Related]  

  • 35. Allosteric effects govern nuclear receptor action: DNA appears as a player.
    Gronemeyer H; Bourguet W
    Sci Signal; 2009 Jun; 2(73):pe34. PubMed ID: 19491383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The nuclear receptor superfamily: A structural perspective.
    Weikum ER; Liu X; Ortlund EA
    Protein Sci; 2018 Nov; 27(11):1876-1892. PubMed ID: 30109749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-depth proteomic characterization of endogenous nuclear receptors in mouse liver.
    Liu Q; Ding C; Liu W; Song L; Liu M; Qi L; Fu T; Malovannaya A; Wang Y; Qin J; Zhen B
    Mol Cell Proteomics; 2013 Feb; 12(2):473-84. PubMed ID: 23197792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet?
    Rudraiah S; Zhang X; Wang L
    Annu Rev Pharmacol Toxicol; 2016; 56():605-626. PubMed ID: 26738480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Research Resources for Nuclear Receptor Signaling Pathways.
    McKenna NJ
    Mol Pharmacol; 2016 Aug; 90(2):153-9. PubMed ID: 27216565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allosteric mechanisms of nuclear receptors: insights from computational simulations.
    Mackinnon JA; Gallastegui N; Osguthorpe DJ; Hagler AT; Estébanez-Perpiñá E
    Mol Cell Endocrinol; 2014 Aug; 393(1-2):75-82. PubMed ID: 24911885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.